The DOI matches its Crossref record; 45 of the 47 references it cites were found in a registry or an index.
Efficacy of selective serotonin-reuptake inhibitors in premenstrual syndrome: a systematic review
Abstract
Background Selective serotonin-reuptake inhibitors (SSRIs) are increasingly being used as first-line therapy for severe premenstrual syndrome (PMS). We undertook a meta-analysis on the efficacy of SSRIs in this disorder.Methods We searched medical and scientific databases, approached pharmaceutical companies, and reviewed citations of relevant articles to identify 29 studies of the use of SSRIs in PMS. 14 were excluded (no placebo group, preliminary report of included trial, or low quality). 15 randomised placebo-controlled trials were included. Information on study design, participants, drugs used and dosing regimens, outcome measures, side-effects, and sources of funding was extracted. Standardised mean differences between treatment and placebo groups were calculated to obtain an overall estimate of efficacy. The primary outcome measure was a reduction in overall PMS symptoms.Findings The primary analysis included data on 904 women (570 assigned active treatment and 435 assigned placebo, including 101 in crossover trials). The overall standardised mean difference was -1.066 (95% CI -1.381 to -0.750), which corresponds to an odds ratio of 6.91 (3.90 to 12.2) in favour of SSRIs. SSRIs were effective in treating physical and behavioural symptoms. There was no significant difference in symptom reduction between continuous and intermittent dosing or between trials funded by pharmaceutical companies and those independently funded. Withdrawal due to side-effects was 2.5 times more likely in the active-treatment group than in the placebo group.Interpretation SSRIs are an effective first-line therapy for severe PMS. The safety of these drugs has been demonstrated in trials of affective disorder, and the side-effects at low doses are generally acceptable.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The SSRIs fluoxetine, paroxetine, sertraline, escitalopram, and citalopram have been proven to reduce several premenstrual syndrome symptoms, although in some cases, side effects have also been reported with a dose-depended relationship [48,49].”
From Antimicrobial Properties of Antidepressants and Antipsychotics—Possibilities and Implications (2021) · cites this paper as [48]
In the citing paper
“Indeed, in these patients during the cure, no recurrent episodes of yeast infection were reported [48,50].”
From Antimicrobial Properties of Antidepressants and Antipsychotics—Possibilities and Implications (2021) · cites this paper as [48]
In the citing paper
“Interestingly, sertraline had also positive effects in women suffering from premenstrual syndrome and recurrent vulvovaginal candidiasis.”
From Antimicrobial Properties of Antidepressants and Antipsychotics—Possibilities and Implications (2021) · cites this paper as [48]
Citations
Cites
Statistical Power Analysis for the Behavioral Sciences
Muller, K. E., & Cohen, J. (1989) · Technometrics · doi:10.2307/1270020 · Cited by 99,603
Statistical power analysis for the behavioral sciences
Cohen, J. (1990) · Computers Environment and Urban Systems · doi:10.1016/0198-9715(90)90050-4 · Cited by 65,417
Bias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722
Assessing the quality of reports of randomized clinical trials: Is blinding necessary?
Jadad, A. R., Moore, R. A., Carroll, D., Jenkinson, C., Reynolds, D. J. M., Gavaghan, D. J., & McQuay, H. J. (1996) · Controlled Clinical Trials · doi:10.1016/0197-2456(95)00134-4 · Cited by 17,582
Wasserman, S. S., Hedges, L. V., & Olkin, I. (1988) · Journal of Educational Statistics · doi:10.2307/1164953 · Cited by 10,377
Statistical Methods for Meta-Analysis.
Freeman, P. R., Hedges, L. V., & Olkin, I. (1986) · Biometrics · doi:10.2307/2531069 · Cited by 4,840
Greene, R., & Dalton, K. (1953) · BMJ · doi:10.1136/bmj.1.4818.1007 · Cited by 1,819
Meta-analysis of screening and diagnostic tests.
Hasselblad, V., & Hedges, L. V. (1995) · Psychological Bulletin · doi:10.1037/0033-2909.117.1.167 · Cited by 579
Fluoxetine in the Treatment of Premenstrual Dysphoria
Steiner, M. S., Steinberg, S. I., Stewart, D. E., Carter, D., Berger, C., Reid, R. L., Grover, D., & Streiner, D. L. (1995) · New England Journal of Medicine · doi:10.1056/nejm199506083322301 · Cited by 450
Progesterone metabolite allopregnanolone in women with premenstrual syndrome
RAPKIN, A., MORGAN, M., GOLDMAN, L., BRANN, D., SIMONE, D., & MAHESH, V (1997) · Obstetrics & Gynecology · doi:10.1016/s0029-7844(97)00417-1 · Cited by 376
Research works printed but not linked: 1
- Rickels, 1990, Fluoxetine in the treatment of premenstrual syundrome, Curr Ther Res, 48, 161
Cited by
Sorted by citations
Items 201–300 of 364
Premenstrual Dysphoric Disorder
Nowakowski, S., Haynes, P. L., & Parry, B. L. (2007) · Elsevier eBooks · doi:10.1016/b978-012373947-6.00304-4 · Cited by 9
The pharmacotherapeutic management of premenstrual dysphoric disorder
Ciccone, N., Kovacheff, M. B., & Frey, B. N. (2022) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2022.2114345 · Cited by 7
Anxiety, Anxiety Disorders, And The Menstrual Cycle
Sigmon, S. T., & Schartel, J. G. (2007) · Springer eBooks · doi:10.1007/978-0-387-74753-8_8 · Cited by 7
Primary and Secondary Dysmenorrhea, Premenstrual Syndrome, and Premenstrual Dysphoric Disorder
Lentz, G. M. (2007) · Elsevier eBooks · doi:10.1016/b978-0-323-02951-3.50039-x · Cited by 7
Treatment of interictal psychiatric disorder in epilepsy. I. Affective and anxiety disorders
van der Feltz-Cornelis, C. (2002) · Acta Neuropsychiatrica · doi:10.1034/j.1601-5215.2002.140106.x · Cited by 7
“(5) suggest a concordance of symptomatology between interictal and premenstrual dysphoric disorder that may extend to treatment; a meta-analysis of the treatment of premenstrual dysphoric disorder in the general population indeed warrants the effectiveness of SSRIs (6).”
BackgroundInfluentialPsychotropic drug epidemiology: The road travelled, the road ahead
Barbui, C., & Tansella, M. (2005) · International Review of Psychiatry · doi:10.1080/09540260500071558 · Cited by 7
Ismail, K. M. K., & O’Brien, P. M. S. (2001) · Current Obstetrics and Gynaecology · doi:10.1054/cuog.2001.0183 · Cited by 7
Self-citationEfficacy of open-label placebos for premenstrual syndrome: a randomised controlled trial
Nascimento, A. F., Gaab, J., Degen, B., Rytz, M., Holder, A., Sezer, D., Buergler, S., Meyer, A. H., Kirsch, I., Kossowsky, J., et al. (2025) · BMJ Evidence-Based Medicine · doi:10.1136/bmjebm-2024-112875 · Cited by 6
“6 Additionally, women with PMS experience over three times more impairment of work productivity than women without PMS. 7 Thus, PMS has detrimental consequences at an individual and economic level.”
InfluentialAnalyzing cyclic patterns in psychological data: A tutorial
Verboon, P., & Leontjevas, R. (2018) · The Quantitative Methods for Psychology · doi:10.20982/tqmp.14.4.p218 · Cited by 5
Duloxetine treatment of Premenstrual Dysphoric Disorder: Case reports
Ramos, M. G., Hara, C., & Rocha, F. L. (2007) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2007.09.006 · Cited by 6
Baehr, E., Miller, L., Rosenfeld, J. P., & Baehr, R. (2004) · Journal of Neurotherapy · doi:10.1300/j184v08n01_03 · Cited by 6
Treatment of premenstrual dysphoria with selective serotonin re-uptake inhibitors: focus on safety
Macdougall, M., & Steiner, M. S. (2003) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2.2.161 · Cited by 6
“[26] recently completed a meta-analysis of data published between 1988 and 1999 from 15 randomised placebo-controlled trials investigating the efficacy of SSRIs for PMS (two-thirds of the trials investigated SSRI treatment in PMDD or LLPDD).”
BackgroundMethodStute, P., & Kiesel, L. (2008) · Gynäkologische Endokrinologie · doi:10.1007/s10304-008-0280-7 · Cited by 5
“Die bilaterale Ovarektomie stellt die letzte Therapieoption dar Sowohl die kontinuierliche als auch die luteale Gabe von Antidepressiva reduzieren PMS- und PMDS-Beschwerden 7 SSRI 7 Langzeitbehandlung GABA Genetik Vulnerabilität ZNS Dysregulation Hypersensitivtät Gonadale Veränderung Eingeschränkte Adaptation Andere Z…”
BackgroundInfluentialPremenstrual syndrome/premenstrual dysphoric disorder
Washington, M., Brown, C., & Ling, F. W. (2015) · Cambridge University Press eBooks · doi:10.1017/cbo9781139628938.004 · Cited by 6
Premenstrual Syndrome: Cyclic Symptoms in Women of Reproductive Age
Mortola, J. F., Brunswick, D. J., & Amsterdam, J. D. (2002) · Psychiatric Annals · doi:10.3928/0048-5713-20020801-05 · Cited by 5
Recognizing and Treating Premenstrual Dysphoric Disorder
Liang, B. A., Batra, P., & Harper, D. M. (2002) · Cited by 5
Keye, W. R. (2004) · Elsevier eBooks · doi:10.1016/b0-12-475570-4/01067-2 · Cited by 5
Modulators of the GABAA receptor
Thomsen, C., & Ebert, B. (2001) · Pharmaceutical science series · doi:10.1201/9780203299388.ch18 · Cited by 5
Retallick-Brown, H., Rucklidge, J. J., & Blampied, N. M. (2016) · Medicines · doi:10.3390/medicines3040032 · Cited by 4
“However, the use of anti-depressants in the treatment of PMS can, at times, cause significant side effects including nausea, loss of libido, fatigue, insomnia, dry mouth, gastrointestinal complaints, and tremors (among other problems) [8], which can cause many women to terminate treatment.”
BackgroundResultAssociation of fine-particulate and acidic-gas air pollution with premenstrual syndrome risk
Lin, S.-Y. G., Yang, Y.-C., Chang, C. Y.-Y., Hsu, W.-H., Lin, C., Jiang, C.-C., Wang, I.-K., Lin, C.-D., Hsu, C.-Y., & Kao, C.-H. (2020) · QJM · doi:10.1093/qjmed/hcaa096 · Cited by 4
Top 100 Cited Papers on Premenstrual Syndrome/Premenstrual Dysphoric Disorder: A Bibliometric Study
Gao, M., Zhang, H., Wang, C., Mou, X., Zhu, Q., Wang, J., & Gao, D. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.936009 · Cited by 4
Evidence-based treatment in family practice
Douglas, S. (2002) · Cited by 4
Gonadal Hormones and Behavior in Women: Concentrations versus Context
Rubinow, D. R., Schmidt, P. J., Meltzer-Brody, S. E., & Harsh, V. (2009) · Elsevier eBooks · doi:10.1016/b978-008088783-8.00076-0 · Cited by 4
Cost-Effectiveness Analysis of Treatments for Premenstrual Dysphoric Disorder
Rendas‐Baum, R., Yang, M. S., Gricar, J., & Wallenstein, G. V. (2010) · Applied Health Economics and Health Policy · doi:10.2165/11532210-000000000-00000 · Cited by 4
“The decision-analytic model and its six-cycle timeframe were structured based on treatment recommendations from experts in the field of women’s health([23,24]) and the number of cycles used in clinical trials of PMDD treatment.([9]) The main components of the model were the primary clinical outcomes and direct costs a…”
BackgroundMethodResultInfluentialElek, T., & Reich, M. (2003) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2003.11.004 · Cited by 4
Effects of the premenstrual syndrome on facial expressions of sadness
Maß, R., Moll, B., Hölldorfer, M., Wiedemann, K., Richter‐Appelt, H., Dahme, B., & WOLF, K. (2008) · Scandinavian Journal of Psychology · doi:10.1111/j.1467-9450.2008.00645.x · Cited by 4
Efficacy of Progesterone and Progestogens in Management of Premenstrual Syndrome: Systematic Review
Wyatt, K. M., Dimmock, P. W., Jones, P., Obhrai, M. S., & O’Brien, S. (2002) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-200204000-00017 · Cited by 4
Self-citationHistory of the premenstrual disorders
ISMAIL, K. M. K. (2007) · CRC Press eBooks · doi:10.3109/9781435628168-2 · Cited by 4
Micronutrient Intake and Premenstrual Syndrome
Chocano-Bedoya, P. O. (2022) · ScholarWorks@UMassAmherst (University of Massachusetts Amherst) · doi:10.7275/2387359 · Cited by 4
Selective Serotonin Reuptake Inhibitors and Treatment of Premenstrual Dysphoric Disorder
Finfgeld, D. L. (2009) · Perspectives In Psychiatric Care · doi:10.1111/j.1744-6163.2002.tb00657.x · Cited by 4
(2001) · BMJ · doi:10.1136/bmj.323.7316.780 · Cited by 4
Twogood, S., & Israel, J. (2010) · doi:10.1002/9781444323030.ch59 · Cited by 4
Jafarirad, S. (2017) · MOJ Food Processing & Technology · doi:10.15406/mojfpt.2017.05.00131 · Cited by 3
Characteristics of the Gut Microbiota in Japanese Patients with Premenstrual Syndrome
Okuma, K., Kono, K., Otaka, M., Ebara, A., Odachi, A., Tokuno, H., & Masuyama, H. (2022) · International Journal of Women s Health · doi:10.2147/ijwh.s377066 · Cited by 4
“This report was not consistent with the results of the present study, which showed that PMDs were associated with PMS, as well as with the symptoms that occur with nonovulatory ovarian activity and are iatrogenically generated following hormone therapy.(8) These differences in symptoms may account for the differences…”
BackgroundResultSíndrome pré-menstrual e síndrome disfórica pré-menstrual: aspectos atuais
Brilhante, A. V. M., Bilhar, A. P. M., Carvalho, C. B., Karbage, S. A. L., Filho, E. P. P., & da Rocha, E. S. (2010) · Cited by 3
O’Brien, P. M. S. (2012) · Wiley-Blackwell eBooks · doi:10.1002/9781119979449.ch43 · Cited by 3
Self-citationMizgier, M., Jarząbek‐Bielecka, G., Drejza, M. A., Luwański, D., Wójcik, M., Plagens-Rotman, K., Goździewicz, T., Pisarska-Krawczyk, M., & Kędzia, W. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12124015 · Cited by 3
“Furthermore, any reports during the interview of irregular menstruations, taking hormonal medicines such as oral contraceptives, medicines that can have an impact on the functioning of the axis hypothalamus—pituitary—gonads (HPG) axis and dietary supplements were also taken into account [3,4,17,24].”
BackgroundWinther, K., Campbell-Tofte, J., Motawei, A. M., Pedersen, F. H., Roos, S. B., Hansen, A. S. V., Gleerup, G., Killi, M., & Gerhardsen, G. (2018) · Journal of Herbal Medicine · doi:10.1016/j.hermed.2018.02.002 · Cited by 3
Evidence-based management of premenstrual syndrome
Thangaratinam, S., ISMAIL, K. M. K., & O'Brien, S. (2006) · European Clinics in Obstetrics and Gynaecology · doi:10.1007/s11296-006-0031-z · Cited by 3
Management of premenstrual dysphoric disorder
Brechin, S. J. G., & Owen, P. (2003) · Hospital Medicine · doi:10.12968/hosp.2003.64.6.348 · Cited by 3
Premenstrual Syndromes—An Approach to Diagnosis and Treatment
Swart, P. J., & Dreyer, G. (2007) · South African Family Practice · doi:10.1080/20786204.2007.10873527 · Cited by 3
Kasgari, K. A., Hosseini, Z. S., & Danesh, M. (2008) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 3
Physical Activity and Neural Correlates of Sad Facial Expressions in Premenstrual Syndrome
Hwang, R.-J. (2018) · Journal of Gynecology and Obstetrics · doi:10.11648/j.jgo.20180603.14 · Cited by 3
“Premenstrual syndrome (PMS) has a high morbidity level, reaching 30–80% among women at reproductive age [1, 2].”
BackgroundBakay, K., Ulubaşoğlu, H., Atan, T., Alaçam, H. A., Güven, D., & Batioglu, S. (2018) · Clinical and Experimental Obstetrics & Gynecology · doi:10.12891/ceog4201.2018 · Cited by 3
PROPRIEDADES FUCIONAIS DA SOJA
Dalpizol, B., Lehr, E., Alves, G. B., Rodrigues, F., & Bernardi, D. M. (2020) · FAG JOURNAL OF HEALTH (FJH) · doi:10.35984/fjh.v2i3.230 · Cited by 3
Ismail, K., & O’Brien, S. (2006) · Women s Health Medicine · doi:10.1016/s1744-1870(07)70008-2 · Cited by 3
Kyshakevych, I. T., & Конар, Р. С. (2016) · Reproductive Endocrinology · doi:10.18370/2309-4117.2016.30.82-86 · Cited by 3
Verschoor, E., Finlayson, G., Blundell, J. E., Markus, C. R., & King, N. A. (2010) · British Journal Of Nutrition · doi:10.1017/s0007114510000838 · Cited by 2
Continuing Controversies in the Recognition and Management of Premenstrual Syndromes
Freeman, E. W. (2006) · Women s Health · doi:10.2217/17455057.2.5.665 · Cited by 2
“• The cardinal PMS symptom is irritability, not depression, and the syndrome includes physical symptoms such as breast soreness and swelling, which are not characteristic of depression but respond to SSRI treatment for PMS [10];”
BackgroundRole of Anthropometric Indices in the Appearance of Premenstrual Syndrome in College Students
Vaishampayan, N., & Sneha, Y. L. (2022) · Acta Scientific Women s Health · doi:10.31080/aswh.2022.04.0351 · Cited by 2
Herbal Medicine in the Treatment of Premenstrual Syndromes
Kashani, L., Hajiaghaee, R., & Akhondzadeh, S. (2011) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 2
Premenstrual Syndrome/Premenstrual Dysphoric Disorder
Brown, C., & Ling, F. W. (1996) · Elsevier eBooks · doi:10.1016/b978-0-443-06691-7.50007-8 · Cited by 2
Holsboer‐Trachsler, E., & Holsboer, F. (2011) · Springer eBooks · doi:10.1007/978-3-642-19844-1_53 · Cited by 2
Nutritional and neuroendocrine serotonin regulation can affect pre menstrual syndrome
Mazzini, M. C. R., Grossi, M., & Malheiros, S. V. P. (2013) · Perspectivas Médicas · doi:10.6006/perspectmed.20130107.235678199 · Cited by 2
Kim, S. J. (2015) · Journal of the East Asian Society of Dietary Life · doi:10.17495/easdl.2015.2.25.1.64 · Cited by 2
Premenstrual symptoms in young students and in their mothers at their ages
Miwa, F., Yuna, H., Mari, F., Sayuri, H., & Yasui, T. (2017) · International Journal of Nursing and Midwifery · doi:10.5897/ijnm2017.0275 · Cited by 2
“, 2001) and that about 5% of women have severe symptoms that interfere with personal or social relationships or work and may require pharmacological management (Dimmock et al., 2000).”
BackgroundByrne, R., & Kirschner, K. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-39956-2.00027-3 · Cited by 3
Herbal treatment for premenstrual syndrome
Zheng, J., Chen, X., Ismail, K., & Wu, T. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006414 · Cited by 2
The effect of nutritional supplementation on premenstrual syndrome
Avila, C. (2009) · Cross Connect (Southern Cross University) · Cited by 2
Herbals and Other Dietary Supplements for Premenstrual Syndrome and Menopause
Chavez, M. L., & Spitzer, M. F. (2002) · Psychiatric Annals · doi:10.3928/0048-5713-20020101-10 · Cited by 2
Managing PMS & PMDD: Exploring New Treatment Options
Pritham, U. A. (2002) · AWHONN Lifelines · doi:10.1177/1091592302238929 · Cited by 2
Perinatal and gynaecological disorders
Abel, K. M. (2007) · Cambridge University Press eBooks · doi:10.1017/cbo9780511543975.028 · Cited by 2
SSRIs for premenstrual dysphoric disorder
(2002) · Drug and Therapeutics Bulletin · doi:10.1136/dtb.2002.40970 · Cited by 2
Коcharyan, G. S. (2023) · Health of Man · doi:10.30841/2307-5090.1.2023.280049 · Cited by 1
Walsen, S., Chaves, C., & Baquedano, C. (2026) · Frontiers in Psychology · doi:10.3389/fpsyg.2026.1912206 · Cited by 2
Premenstrual Syndromes: Guidelines for Assessment and Treatment
Macdougall, M., Born, L., Krasnik, C. E., & Steiner, M. S. (2006) · Springer eBooks · doi:10.1007/978-0-387-28370-8_55 · Cited by 1
Premenstrueel syndroomanticonceptie depressie pms
Zondag-Coulier, S. B. M., Eekhof, J., & Neven, A. K. (2002) · Huisarts en Wetenschap · doi:10.1007/bf03082829 · Cited by 1
Troubles dysphoriques prémenstruels : diagnostic et traitements médicamenteux
Benjelloun, G., & Pélissolo, A. (2003) · Annales Médico-psychologiques revue psychiatrique · doi:10.1016/s0003-4487(03)00014-3 · Cited by 1
The surprising activities of APOBEC3B and 5-fluorouracil
Walton, E. L. (2015) · Biomedical Journal · doi:10.4103/2319-4170.154913 · Cited by 1
“Most women neglect the impact of PMS, although in many cases, this condition affects personal re‐ lationships, studies, and work, with several cases requiring pharmacological treatment.([28]) Thus, more should be done to lift the taboo surrounding PMS in Asian countries and raise awareness of this condition.”
BackgroundAgnus castus fruit extract was safe and effective for relieving symptoms of premenstrual syndrome
BMJ Publishing Group Ltd and RCN Publishing Company Ltd (2001) · Evidence-Based Nursing · doi:10.1136/ebn.4.4.114 · Cited by 1
Approches psychothérapiques dans des troubles gynécologiques fonctionnels
Bianchi-Demicheli, F., & Abraham, G. (2004) · Psychothérapies · doi:10.3917/psys.041.0033 · Cited by 1
Pre Menstrual Syndrome: Different Approaches of Management
Tom, N. R., Varghese, G. H., Lakshmi, S., & Sivakumar, T. (2014) · Cited by 1
Psychopharmakotherapie somatoformer Störungen und funktioneller somatischer Syndrome
Kapfhammer, H. (2007) · Psychiatrie und Psychotherapie · doi:10.1007/s11326-007-0072-z · Cited by 1
Zahradnik, H. P. (2004) · Gynäkologische Endokrinologie · doi:10.1007/s10304-004-0060-y · Cited by 1
“depressiven Reaktionen sind selektive Serotoninwiederaufnahmehemmer sowie andere Antidepressiva und eine konsequente Verhaltenstherapie sinnvoll [13].”
BackgroundBieber, E. J., Sanfilippo, J. S., Horowitz, I., & Shafi, M. I. (2015) · Cambridge University Press eBooks · doi:10.1017/cbo9781139628938.003 · Cited by 1
Somatoforme Störungen und Somatisierungssyndrome
Kapfhammer, H. (2011) · Springer eBooks · doi:10.1007/978-3-642-19844-1_81 · Cited by 1
Braverman, P. K., & Breech, L. L. (2008) · Elsevier eBooks · doi:10.1016/b978-032304073-0.10022-6 · Cited by 1
Hormonal Regulation of the Menstrual Cycle, Mechanisms of Ovulation, Premenstrual Syndromes
Marshall, J. C., & Reame, N. K. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-5583-9.00128-3 · Cited by 1
Clinical Characteristics of PMS Co-Morbid with MDD and Effectiveness of SSRIs in its Treatment
Yakimova, R., Stoimenova-Popova, M. Y., Chumpalova, P. G., Pandova, M. S., & Stoyanova, M. B. (2020) · Acta Medica Bulgarica · doi:10.2478/amb-2020-0041 · Cited by 1
“Criteria for evaluation of PMS severity mild/moderate PMS severe PMS (PMDD) At least one question from 1 to 4 evaluated as mild/ moderate At least one question from 1 to 4 evaluated as severe At least four questions from 1 to 19 evaluated as mild/ moderate At least four questions from 1 to 19 evaluated as severe Quest…”
BackgroundInfluentialLaux, G. (2017) · Springer eBooks · doi:10.1007/978-3-662-49295-6_67 · Cited by 2
Primary and Secondary Dysmenorrhea, Premenstrual Syndrome, and Premenstrual Dysphoric Disorder
Lentz, G. M. (2012) · Elsevier eBooks · doi:10.1016/b978-0-323-06986-1.00036-6 · Cited by 1
Premenstrual dysphoric disorder and premenstrual syndrome: an overview
Bharti, S., Kohli, A., Tripathi, A., & Sharma, R. (2014) · Sri Lanka Journal of Psychiatry · doi:10.4038/sljpsyc.v5i2.7814 · Cited by 1
Premenstrual Syndrome and Self-Medication With Opioids
Qurishi, R., Sonneborn, C., de Jong-Arts, M., & de Jong, C. D. (2013) · Journal of Addiction Medicine · doi:10.1097/adm.0b013e31827884a3 · Cited by 1
“A meta-analysis of 904 patients compared the efficacy of SSRIs with placebo (Dimmock et al., 2000).”
MethodRegulação nutricional e neuroendócrina da serotonina podem influenciar a síndrome pré menstrual.
Mazzini, M. C. R., Grossi, M., & Malheiros, S. V. P. (2013) · Perspectivas Médicas · Cited by 1
Premenstrual Syndrome- A Short Review
Cruz, J. D. J. (2016) · Obstetrics & Gynecology International Journal · doi:10.15406/ogij.2016.05.00164 · Cited by 1
Diagnosis and Treatment of Premenstrual Syndrome
Shoupe, D. (2016) · Springer eBooks · doi:10.1007/978-3-319-17002-2_33-1 · Cited by 1
Diagnosis and Treatment of Premenstrual Syndrome
Shoupe, D. (2017) · Springer eBooks · doi:10.1007/978-3-319-17798-4_33 · Cited by 1
Effect of Pranayama on premenstrual syndrome in the present scenario
Banwal, S., & Siddiqui, Z. U. (2022) · International Journal of Health Sciences · doi:10.53730/ijhs.v6ns2.6690 · Cited by 3
Prescribing patterns of antidepressants with known off–label indications among adults
Roux, L., & Daniël, J. (2014) · Cited by 1
Premenstrual dysphoric disorder in relation to neuroactive steroids and alcohol
Nyberg, S. (2006) · KTH Publication Database DiVA (KTH Royal Institute of Technology) · Cited by 1
La sindrome premestruale - un modello clinico di compromesso psiconeuroendocrino ciclico
Nappi, R. E., Sommacal, A., Detaddei, S., Sances, G., Ornati, A., Brundu, B., Ballario, P., Albani, F. L. M., & Polatti, F. (2006) · CNR Solar (Scientific Open-access Literature Archive and Repository) (Consiglio Nazionale delle Ricerche) · Cited by 1
Neuroactive steroids and rat CNS
Birzniece, V. (2004) · KTH Publication Database DiVA (KTH Royal Institute of Technology) · Cited by 1
Paroxetine Use in the Treatment of Premenstrual Dysphoric Disorder
Misri, S. K., & Kendrick, K. (2005) · Women s Health · doi:10.2217/17455057.2.1.43 · Cited by 1
“Although continuous (daily) dosing of the SSRIs is an effective treatment for PMDD, as women are generally only symptomatic for up to 14 days of their menstrual cycle, intermittent dosing is a mode of treatment found to be equally successful [36].”
BackgroundPremenstrual syndrome in primary care: an update
Condon, J. T. (2007) · Primary Care and Community Psychiatry · doi:10.1185/135525706x121165 · Cited by 1
“(A) Five or more of the following 11 symptoms occurring premenstrually on most menstrual cycles with full remission in the week post menses [at least one of the symptoms being (1), (2), (3), or (4)] (1) Depression/hopelessness (2) Anxiety/tension (3) Mood swings/lability of affect (4) Anger/irritability (5) Decreased…”
BackgroundBarry, L. (2016) · Memorial University Research Repository (Memorial University) · Cited by 1
Kapfhemmer, H.-P. (2008) · Springer eBooks · doi:10.1007/978-3-540-68748-1_46 · Cited by 1
Psychopharmaka in der Frauenheilkunde
Rohde, A. (2008) · Gynäkologische Endokrinologie · doi:10.1007/s10304-008-0270-9
Hormonal Contraception and Sterilisation
Rosevear, S. K. (2002) · doi:10.1002/9780470774397.ch1
McGrath, P. J., & Roose, S. P. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9781139175869.004
Frauenspezifische psychische Störungen in der Psychiatrie
Rohde, A. (2008) · Springer eBooks · doi:10.1007/978-3-540-33129-2_74
Metadata
- Authors
- Dimmock, P. W., Wyatt, K. M., Jones, P. W., & O'Brien, P. S.
- Affiliations
- University Hospitals of North Midlands NHS Trust (GB)
- Keele University (GB)
- Corresponding author
- Dimmock, Paul W
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 2000-09
- Volume
- 356
- Issue
- 9236
- Pages
- 1131-1136
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- OpenAlex
- W2119435034
- Cited by
- 368
- References
- 47
- Citations by year
- 2026: 7 · 2025: 3 · 2024: 6 · 2023: 10 · 2022: 11 · 2021: 4 · 2020: 4 · 2019: 7 · 2018: 9 · 2017: 11 · 2016: 16 · 2015: 14 · 2014: 11 · 2013: 13 · 2012: 10
- FWCI
- 5.88
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Lancet (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Menstrual Health and Disorders
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Maternal Mental Health During Pregnancy and Postpartum
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
- Keywords
- selective serotonin reuptake inhibitors, premenstrual syndrome, drug efficacy, pharmaceutical industry funding, adverse drug reactions, first-line therapy
- MeSH terms
- Female, Humans, Patient Dropouts, Premenstrual Syndrome, Randomized Controlled Trials as Topic, Treatment Outcome, Selective Serotonin Reuptake Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
